[go: up one dir, main page]

MA38171A1 - Insuffisance rénale aigue - Google Patents

Insuffisance rénale aigue

Info

Publication number
MA38171A1
MA38171A1 MA38171A MA38171A MA38171A1 MA 38171 A1 MA38171 A1 MA 38171A1 MA 38171 A MA38171 A MA 38171A MA 38171 A MA38171 A MA 38171A MA 38171 A1 MA38171 A1 MA 38171A1
Authority
MA
Morocco
Prior art keywords
renal failure
acute renal
predicting
severity
relates
Prior art date
Application number
MA38171A
Other languages
English (en)
Other versions
MA38171B1 (fr
Inventor
Frank Dieterle
Holger Hoefling
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA38171A1 publication Critical patent/MA38171A1/fr
Publication of MA38171B1 publication Critical patent/MA38171B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé de prédiction de la gravité d'une insuffisance rénale aigue suite à une chirurgie cardiaque.
MA38171A 2012-12-20 2013-12-18 Évaluation du risque d’insuffisance rénale aiguë suite a une chirurgie cardiaque MA38171B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261740303P 2012-12-20 2012-12-20
PCT/EP2013/077253 WO2014096110A1 (fr) 2012-12-20 2013-12-18 Insuffisance rénale aiguë

Publications (2)

Publication Number Publication Date
MA38171A1 true MA38171A1 (fr) 2016-11-30
MA38171B1 MA38171B1 (fr) 2017-07-31

Family

ID=49885245

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38171A MA38171B1 (fr) 2012-12-20 2013-12-18 Évaluation du risque d’insuffisance rénale aiguë suite a une chirurgie cardiaque

Country Status (20)

Country Link
US (1) US20150309052A1 (fr)
EP (1) EP2936160A1 (fr)
JP (2) JP6416778B2 (fr)
KR (1) KR20150096728A (fr)
CN (1) CN104871004A (fr)
AR (1) AR094118A1 (fr)
AU (2) AU2013360685A1 (fr)
BR (1) BR112015014232A2 (fr)
CA (1) CA2895096A1 (fr)
CL (1) CL2015001768A1 (fr)
HK (1) HK1209838A1 (fr)
IL (1) IL239431A0 (fr)
MA (1) MA38171B1 (fr)
MX (1) MX2015008108A (fr)
PH (1) PH12015501399A1 (fr)
RU (1) RU2015129496A (fr)
SG (1) SG11201504329RA (fr)
TN (1) TN2015000263A1 (fr)
TW (1) TW201430347A (fr)
WO (1) WO2014096110A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019037043A1 (fr) * 2017-08-24 2019-02-28 菲鹏生物股份有限公司 Kit de détection d'une lésion rénale aiguë
CN108986915B (zh) * 2018-07-24 2021-07-06 戴松世 人工智能的急性肾损伤的早期预测方法和装置
WO2020064995A1 (fr) * 2018-09-28 2020-04-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Utilisation de biomarqueurs représentant des voies cardiaques, vasculaires et inflammatoires permettant la prédiction d'une lésion rénale aiguë chez des patients atteints de diabète de type 2
KR20200042725A (ko) 2018-10-16 2020-04-24 (주) 솔 렌즈 프리 cmos 광자 어레이 센서의 노이즈 특성 평가 방법
US20220301711A1 (en) * 2019-06-11 2022-09-22 The Regents Of The University Of California Systems and Methods for Machine Learning-based Identification of Acute Kidney Injury in Trauma Surgery and Burned Patients
CN110441457A (zh) * 2019-08-02 2019-11-12 深圳市绿航星际太空科技研究院 一种检测尿液中同型半胱氨酸的方法
CN112114125A (zh) * 2020-08-27 2020-12-22 中国医学科学院北京协和医院 一种评估肾脏储备功能的方法和系统及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004511807A (ja) * 2000-10-17 2004-04-15 ベッスト−テスト　アンパーツゼルスカブ 体液サンプル中のｒｓウイルスに関連した生物学的細胞の直接的検出のためのアッセイ
JP2004511808A (ja) * 2000-10-17 2004-04-15 ベッスト−テスト　アンパーツゼルスカブ 体液サンプル中の生物学的細胞の直接的検出のためのアッセイ
AU2001295442A1 (en) * 2000-10-17 2002-04-29 Besst-Test Aps Assay for directly detecting an inflammatory indicator in a body fluid sample
US20090238812A1 (en) * 2008-03-18 2009-09-24 Biotrin Intellectual Properties Limited Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery
MX2011004767A (es) * 2008-11-10 2011-09-06 Astute Medical Inc Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
US20110287964A1 (en) * 2008-11-17 2011-11-24 The Brigham And Women's Hospital, Inc. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans
CA2744434C (fr) * 2008-11-21 2017-10-03 Phadia Ab Procedes, dispositifs et kits pour detecter ou surveiller une insuffisance renale severe
CN101706497A (zh) * 2009-11-05 2010-05-12 武汉三鹰生物技术有限公司 人tff3的elisa检测试剂盒
CN104793000A (zh) * 2009-11-07 2015-07-22 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
AU2011250940B2 (en) * 2010-05-10 2016-02-25 Austin Health Markers for acute kidney injury
WO2012094657A1 (fr) * 2011-01-08 2012-07-12 Astute Medical, Inc. Procédé et compositions pour diagnostiquer et pronostiquer une lésion rénale et une insuffisance rénale

Also Published As

Publication number Publication date
IL239431A0 (en) 2015-07-30
WO2014096110A1 (fr) 2014-06-26
CL2015001768A1 (es) 2015-10-09
JP2019053067A (ja) 2019-04-04
AU2013360685A1 (en) 2015-07-02
US20150309052A1 (en) 2015-10-29
AU2017232081A1 (en) 2017-10-12
MX2015008108A (es) 2015-11-06
AR094118A1 (es) 2015-07-08
JP2016503162A (ja) 2016-02-01
TW201430347A (zh) 2014-08-01
KR20150096728A (ko) 2015-08-25
CA2895096A1 (fr) 2014-06-26
RU2015129496A (ru) 2017-01-26
MA38171B1 (fr) 2017-07-31
TN2015000263A1 (fr) 2016-10-03
BR112015014232A2 (pt) 2017-07-11
JP6416778B2 (ja) 2018-10-31
SG11201504329RA (en) 2015-07-30
PH12015501399A1 (en) 2015-09-07
CN104871004A (zh) 2015-08-26
EP2936160A1 (fr) 2015-10-28
HK1209838A1 (en) 2016-04-08

Similar Documents

Publication Publication Date Title
MA38171A1 (fr) Insuffisance rénale aigue
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
CY1121981T1 (el) Μεθοδος για τον προσδιορισμο κινδυνου pml
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
EA201200239A1 (ru) Бициклические арильные аналоги сфингозин 1-фосфата
UY34216A (es) Nuevos compuestos que inhiben la actividad de la Lp-PLA2
EP2689548A4 (fr) Système de détection de rupture associé à un onduleur ou à une machine
EP2715041A4 (fr) Ensemble de jonction de forages multiples à haute pression
EP2828765A4 (fr) Détection cohérente, étendue à une grappe, de défaillances d'interconnexion
EP2756383A4 (fr) Corrélation de journal d'événements entre machines
FR3004421B1 (fr) Procedes pour predire une defaillance d'un systeme d'aerofreins
EP2705475A4 (fr) Systèmes de gestion de médicaments à l'échelle d'une installation
BR112014001004A2 (pt) método para determinar a condição operacional futura de um objeto
EP2862032A4 (fr) Prédiction fiable de l'utilisation de la durée de vie d'un composant de machine
EP2737851A4 (fr) Lancette de sécurité ayant une fonction de prévention de réutilisation à sécurité intégrée
EP2797592A4 (fr) Composés de traitement d'une amyotrophie spinale
EP2552456A4 (fr) Thérapie siarn pour amylose oculaire liée à la transthyrétine (ttr)
IN2014DN04645A (fr)
FR2988271B1 (fr) Systeme de verrouillage rapide d'une piece amovible interchangeable, notamment un bracelet-montre
EP2885968A4 (fr) Méthode servant à arrêter la nage ou la reptation de larves en période de fixation
EP2803120A4 (fr) Système laser monomode, monofréquence à génération d'harmoniques
EP2916662A4 (fr) Composition d'huile végétale destinée à réduire le taux de cholestérol plasmatique
EP2749015A4 (fr) Procédé de gestion automatisée de contacts sortants requérant une connexion assurée à un agent vivant
EP2898722A4 (fr) Procédé de prise en charge de l'indication d'un événement d'échec à un système d'accès source
MA39185A1 (fr) Teledistribution d'une mise a jour logicielle a des terminaux de tele-releve